recurrent cervical cancer

Known as: Cervical Carcinoma Recurrent, Recurrent Carcinoma of the Cervix, Relapsed Carcinoma of Uterine Cervix 
The reemergence of cervical carcinoma after a period of remission.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
PURPOSE Pazopanib and lapatinib are tyrosine kinase inhibitors that target vascular endothelial growth factor receptor, platelet… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE Assess toxicity and efficacy of cisplatin (Cis) doublet combinations in advanced and recurrent cervical carcinoma… (More)
  • figure 1
  • table 1
  • table 3
  • table 2
  • table 4
Is this relevant?
Highly Cited
2009
Highly Cited
2009
PURPOSE Vascular endothelial growth factor is a key promoter of tumor progression in cervical carcinoma. The Gynecologic Oncology… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2009
2009
OBJECTIVES The purpose of this study was to evaluate the activity and toxicity of carboplatin and paclitaxel combination in… (More)
Is this relevant?
2006
2006
OBJECTIVE To report the utility of the monoclonal, anti-vascular endothelial growth factor antibody bevacizumab in combination… (More)
Is this relevant?
Review
2004
Review
2004
Approximately 30% of cervical cancer patients will ultimately fail after definitive treatment. The reported 5-year survival rates… (More)
Is this relevant?
Review
2003
Review
2003
Cervical cancer is a serious health problem, with nearly 500000 women developing the disease each year worldwide. Most cases… (More)
Is this relevant?
Review
2002
Review
2002
There are limited treatment options for patients with recurrent cervical carcinoma. Because of low response rates and a… (More)
Is this relevant?
1999
1999
OBJECTIVE This study was undertaken to investigate prognostic factors in patients with recurrent cervical carcinoma who had… (More)
Is this relevant?
1988
1988
The characteristics of recurrent carcinoma following radical hysterectomy and pelvic lymphadenectomy for cervical carcinoma are… (More)
Is this relevant?